🇺🇸 FDA
Patent

US 7560471

Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

granted A61PA61P11/06A61P17/00

Quick answer

US patent 7560471 (Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents) held by Laboratories Almirall, S.A. expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P11/06, A61P17/00, A61P27/02, A61P27/16